280 related articles for article (PubMed ID: 38173017)
1. Blockage of VEGF function by bevacizumab alleviates early-stage cerebrovascular dysfunction and improves cognitive function in a mouse model of Alzheimer's disease.
Zhang M; Zhang Z; Li H; Xia Y; Xing M; Xiao C; Cai W; Bu L; Li Y; Park TE; Tang Y; Ye X; Lin WJ
Transl Neurodegener; 2024 Jan; 13(1):1. PubMed ID: 38173017
[TBL] [Abstract][Full Text] [Related]
2. MK-0677, a Ghrelin Agonist, Alleviates Amyloid Beta-Related Pathology in 5XFAD Mice, an Animal Model of Alzheimer's Disease.
Jeong YO; Shin SJ; Park JY; Ku BK; Song JS; Kim JJ; Jeon SG; Lee SM; Moon M
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29912176
[TBL] [Abstract][Full Text] [Related]
3. 14,15-Epoxyeicosatrienoic Acid Alleviates Pathology in a Mouse Model of Alzheimer's Disease.
Chen W; Wang M; Zhu M; Xiong W; Qin X; Zhu X
J Neurosci; 2020 Oct; 40(42):8188-8203. PubMed ID: 32973044
[TBL] [Abstract][Full Text] [Related]
4. Fruquintinib/HMPL-013 ameliorates cognitive impairments and pathology in a mouse model of cerebral amyloid angiopathy (CAA).
Zhou G; Xiang T; Xu Y; He B; Wu L; Zhu G; Xie J; Yao L; Xiao Z
Eur J Pharmacol; 2023 Jan; 939():175446. PubMed ID: 36470443
[TBL] [Abstract][Full Text] [Related]
5. BHBA treatment improves cognitive function by targeting pleiotropic mechanisms in transgenic mouse model of Alzheimer's disease.
Wu Y; Gong Y; Luan Y; Li Y; Liu J; Yue Z; Yuan B; Sun J; Xie C; Li L; Zhen J; Jin X; Zheng Y; Wang X; Xie L; Wang W
FASEB J; 2020 Jan; 34(1):1412-1429. PubMed ID: 31914599
[TBL] [Abstract][Full Text] [Related]
6. Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves
DeBay DR; Reid GA; Macdonald IR; Mawko G; Burrell S; Martin E; Bowen CV; Darvesh S
Brain Res; 2017 Sep; 1671():102-110. PubMed ID: 28729192
[TBL] [Abstract][Full Text] [Related]
7. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease.
Kuznetsova E; Schliebs R
Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514
[TBL] [Abstract][Full Text] [Related]
8. Reversing pathology in a preclinical model of Alzheimer's disease by hacking cerebrovascular neoangiogenesis with advanced cancer therapeutics.
Singh CSB; Choi KB; Munro L; Wang HY; Pfeifer CG; Jefferies WA
EBioMedicine; 2021 Sep; 71():103503. PubMed ID: 34534764
[TBL] [Abstract][Full Text] [Related]
9. Association of cerebrovascular dysfunction with the development of Alzheimer's disease-like pathology in OXYS rats.
Stefanova NA; Maksimova KY; Rudnitskaya EA; Muraleva NA; Kolosova NG
BMC Genomics; 2018 Feb; 19(Suppl 3):75. PubMed ID: 29504901
[TBL] [Abstract][Full Text] [Related]
10. TrkB reduction exacerbates Alzheimer's disease-like signaling aberrations and memory deficits without affecting β-amyloidosis in 5XFAD mice.
Devi L; Ohno M
Transl Psychiatry; 2015 May; 5(5):e562. PubMed ID: 25942043
[TBL] [Abstract][Full Text] [Related]
11. Genetic reductions of beta-site amyloid precursor protein-cleaving enzyme 1 and amyloid-beta ameliorate impairment of conditioned taste aversion memory in 5XFAD Alzheimer's disease model mice.
Devi L; Ohno M
Eur J Neurosci; 2010 Jan; 31(1):110-8. PubMed ID: 20092558
[TBL] [Abstract][Full Text] [Related]
12. Sodium Butyrate Reduces Brain Amyloid-β Levels and Improves Cognitive Memory Performance in an Alzheimer's Disease Transgenic Mouse Model at an Early Disease Stage.
Fernando WMADB; Martins IJ; Morici M; Bharadwaj P; Rainey-Smith SR; Lim WLF; Martins RN
J Alzheimers Dis; 2020; 74(1):91-99. PubMed ID: 31958090
[TBL] [Abstract][Full Text] [Related]
13. Amyloid β Protein Aggravates Neuronal Senescence and Cognitive Deficits in 5XFAD Mouse Model of Alzheimer's Disease.
Wei Z; Chen XC; Song Y; Pan XD; Dai XM; Zhang J; Cui XL; Wu XL; Zhu YG
Chin Med J (Engl); 2016 Aug; 129(15):1835-44. PubMed ID: 27453234
[TBL] [Abstract][Full Text] [Related]
14. LPS priming before plaque deposition impedes microglial activation and restrains Aβ pathology in the 5xFAD mouse model of Alzheimer's disease.
Yang Y; García-Cruzado M; Zeng H; Camprubí-Ferrer L; Bahatyrevich-Kharitonik B; Bachiller S; Deierborg T
Brain Behav Immun; 2023 Oct; 113():228-247. PubMed ID: 37437821
[TBL] [Abstract][Full Text] [Related]
15. Deletion of the Inflammasome Sensor Aim2 Mitigates Aβ Deposition and Microglial Activation but Increases Inflammatory Cytokine Expression in an Alzheimer Disease Mouse Model.
Wu PJ; Hung YF; Liu HY; Hsueh YP
Neuroimmunomodulation; 2017; 24(1):29-39. PubMed ID: 28618410
[TBL] [Abstract][Full Text] [Related]
16. L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer's disease.
Peng Y; Sun J; Hon S; Nylander AN; Xia W; Feng Y; Wang X; Lemere CA
J Neurosci; 2010 Jun; 30(24):8180-9. PubMed ID: 20554868
[TBL] [Abstract][Full Text] [Related]
17. Neutral Sphingomyelinase-2 Deficiency Ameliorates Alzheimer's Disease Pathology and Improves Cognition in the 5XFAD Mouse.
Dinkins MB; Enasko J; Hernandez C; Wang G; Kong J; Helwa I; Liu Y; Terry AV; Bieberich E
J Neurosci; 2016 Aug; 36(33):8653-67. PubMed ID: 27535912
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Colony-Stimulating Factor 1 Receptor by PLX3397 Prevents Amyloid Beta Pathology and Rescues Dopaminergic Signaling in Aging 5xFAD Mice.
Son Y; Jeong YJ; Shin NR; Oh SJ; Nam KR; Choi HD; Choi JY; Lee HJ
Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32756440
[TBL] [Abstract][Full Text] [Related]
19. Tripchlorolide improves cognitive deficits by reducing amyloid β and upregulating synapse-related proteins in a transgenic model of Alzheimer's Disease.
Zeng Y; Zhang J; Zhu Y; Zhang J; Shen H; Lu J; Pan X; Lin N; Dai X; Zhou M; Chen X
J Neurochem; 2015 Apr; 133(1):38-52. PubMed ID: 25661995
[TBL] [Abstract][Full Text] [Related]
20. Vasoactive Intestinal Peptide Decreases β-Amyloid Accumulation and Prevents Brain Atrophy in the 5xFAD Mouse Model of Alzheimer's Disease.
Korkmaz OT; Ay H; Aytan N; Carreras I; Kowall NW; Dedeoglu A; Tuncel N
J Mol Neurosci; 2019 Jul; 68(3):389-396. PubMed ID: 30498985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]